Yanqing Li

2.8k total citations · 1 hit paper
104 papers, 1.9k citations indexed

About

Yanqing Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yanqing Li has authored 104 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 35 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Yanqing Li's work include RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (16 papers) and Drug Transport and Resistance Mechanisms (14 papers). Yanqing Li is often cited by papers focused on RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (16 papers) and Drug Transport and Resistance Mechanisms (14 papers). Yanqing Li collaborates with scholars based in China, United States and Taiwan. Yanqing Li's co-authors include Yan Jiao, Yahui Liu, Yue‐Chen Zhao, Ruifeng Zhang, Feng Wang, Tiejun Wang, Zhuo Fu, Chung‐Pu Wu, Yang Li and Suresh V. Ambudkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Yanqing Li

101 papers receiving 1.9k citations

Hit Papers

<p>The Role of Erastin in Ferroptosis and Its Prosp... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. <p>The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy</p>
    2020 324 citations Yanqing Li, Yan Jiao et al. OncoTargets and Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanqing Li China 25 1.2k 748 469 399 171 104 1.9k
Shuangshuang Zeng China 27 1.4k 1.2× 805 1.1× 403 0.9× 324 0.8× 290 1.7× 56 2.0k
Jing Lin China 26 1.1k 1.0× 522 0.7× 215 0.5× 374 0.9× 152 0.9× 67 1.8k
Yahui Ding China 23 976 0.8× 506 0.7× 295 0.6× 247 0.6× 201 1.2× 87 1.8k
Pei Zhang China 23 1.2k 1.0× 636 0.9× 375 0.8× 356 0.9× 368 2.2× 109 2.1k
Qiaoyou Weng China 26 1.3k 1.1× 640 0.9× 619 1.3× 293 0.7× 216 1.3× 77 2.2k
Keqiang Zhang China 29 1.2k 1.0× 682 0.9× 267 0.6× 456 1.1× 109 0.6× 75 1.9k

Countries citing papers authored by Yanqing Li

Since Specialization
Citations

This map shows the geographic impact of Yanqing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanqing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanqing Li more than expected).

Fields of papers citing papers by Yanqing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanqing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanqing Li. The network helps show where Yanqing Li may publish in the future.

Co-authorship network of co-authors of Yanqing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yanqing Li. A scholar is included among the top collaborators of Yanqing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanqing Li. Yanqing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Wenchao, Yajing Wang, Xiaomin Sun, et al.. (2025). Straw Incorporation Mitigating Fertiliser‐Induced Nitrous Oxide Emissions in Intensively Managed Protected Vegetable Soils. Soil Use and Management. 41(2).
2.
Li, Yanqing, et al.. (2025). A proton pump inhibitor-programmed ROS generator enhances the synergistic efficacy of chemo-/chemodynamic therapy with reduced renal injury. Chemical Engineering Journal. 505. 159201–159201. 4 indexed citations
3.
Li, Yanqing & Xiaofei Cheng. (2024). Enhancing Colorectal Cancer Immunotherapy: The Pivotal Role of Ferroptosis in Modulating the Tumor Microenvironment. International Journal of Molecular Sciences. 25(17). 9141–9141. 3 indexed citations
4.
Chen, Zhen, Shilei Wang, Yi He, et al.. (2024). Sustainable production of extracellular polymeric substances and iron or copper complex from glutinous rice processing wastewater. Frontiers in Sustainable Food Systems. 8. 1 indexed citations
5.
Lv, Xiaofei, Xiaoshan Lin, Shengli Chen, et al.. (2023). Modulation Effects of the CEP128 Gene on Radiotherapy‐Related Brain Injury: A Longitudinal Structural Study Using Multi‐Parametric Brain MR Images. Journal of Magnetic Resonance Imaging. 59(2). 648–658. 3 indexed citations
6.
Li, Yanqing, Xiaofei Cheng, Chenhan Zhong, & Ying Yuan. (2023). Primary Tumor Resection Plus Chemotherapy versus Chemotherapy Alone for Colorectal Cancer Patients with Synchronous Bone Metastasis. Medicina. 59(8). 1384–1384.
7.
Liu, Zhicheng, et al.. (2020). HN1 as a diagnostic and prognostic biomarker for liver cancer. Bioscience Reports. 40(7). 11 indexed citations
8.
9.
Li, Yanqing, et al.. (2020). <p>Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer</p>. OncoTargets and Therapy. Volume 13. 11583–11594. 20 indexed citations
10.
Wang, Ruobing, Yan Jiao, Yanqing Li, et al.. (2020). The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer. BioMed Research International. 2020(1). 9519235–9519235. 3 indexed citations
11.
12.
Jiao, Yan, Yanqing Li, Zhuo Fu, et al.. (2019). OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients. Disease Markers. 2019. 1–9. 25 indexed citations
13.
Nie, Yuanyuan, Yan Jiao, Yanqing Li, & Wei Li. (2019). Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer. BioMed Research International. 2019. 1–13. 17 indexed citations
14.
Wu, Chung‐Pu, Megumi Murakami, Sung-Han Hsiao, et al.. (2018). SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Letters. 433. 259–272. 18 indexed citations
15.
Wang, Xin, Yanqing Li, Wei Chen, et al.. (2017). Nrf-2/Gst-α mediated imatinib resistance through rapid 4-HNE clearance. Experimental Cell Research. 353(2). 72–78. 6 indexed citations
16.
Wang, Dongyang, Yuanxu Guo, Yanqing Li, et al.. (2015). Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody. Oncology Letters. 9(6). 2603–2608. 22 indexed citations
17.
Shang, Hua, et al.. (2014). A germline mutation in the miR-125a coding region reduces miR-125a expression and is associated with human gastric cancer. Molecular Medicine Reports. 10(4). 1839–1844. 11 indexed citations
18.
Wang, Min, Shuo Chen, Ying Qing, et al.. (2013). [Effects of autophagy modulator on autophagy and uridine 5'-diphospho-glucuronosyltransferase 1A1 induced by sulforaphane].. Zhonghua yixue zazhi. 93(8). 614–8. 3 indexed citations
19.
Wu, Chung‐Pu, Sung-Han Hsiao, Hong‐May Sim, et al.. (2013). Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1. Biochemical Pharmacology. 86(7). 904–913. 29 indexed citations
20.
Li, Yanqing, et al.. (2007). Inhibition of Epigallocatechin Gallate on Orthotopic Colon Cancer by Upregulating the Nrf2-UGT1A Signal Pathway in Nude Mice. Pharmacology. 80(4). 269–278. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuangshuang Zeng Breakdown of academic impact, for papers by Jing Lin Breakdown of academic impact, for papers by Yahui Ding Breakdown of academic impact, for papers by Pei Zhang Breakdown of academic impact, for papers by Qiaoyou Weng Breakdown of academic impact, for papers by Keqiang Zhang
Rankless by CCL
2026